http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-HER2%E5%9F%BA%E5%9B%A0%E6%89%A9%E5%A2%9E 2026-04-28T21:50:46Z 本wiki的该页面的版本历史 MediaWiki 1.30.0 http://120.24.161.253:5617/index.php?title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-HER2%E5%9F%BA%E5%9B%A0%E6%89%A9%E5%A2%9E&diff=1643078&oldid=prev 2024-07-06T14:00:00Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-HER2%E5%9F%BA%E5%9B%A0%E6%89%A9%E5%A2%9E&diff=1643079&oldid=prev 2024-07-06T12:35:43Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 12:35的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l10" >第10行：</td> <td colspan="2" class="diff-lineno">第10行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===FISH检测乳腺癌HER2基因扩增及临床病理关系的研究（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===FISH检测乳腺癌HER2基因扩增及临床病理关系的研究（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>结果:105例[[乳腺癌]]中共有39例[[HER2基因扩增]],阳性率为37.1% (39/105),其扩增与HER2蛋白过表达、组织学分级、雌激素和孕激素受体(均P<del class="diffchange diffchange-inline">&lt;</del>0.05)状态有关;FISH与IHC两种方法检测HER2结果密切相关(rs=0.680,P<del class="diffchange diffchange-inline">&lt;</del>0.05)</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>结果:105例[[乳腺癌]]中共有39例[[HER2基因扩增]],阳性率为37.1% (39/105),其扩增与HER2蛋白过表达、组织学分级、雌激素和孕激素受体(均P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.05)状态有关;FISH与IHC两种方法检测HER2结果密切相关(rs=0.680,P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.05)</div></td></tr> </table>

KGadmin http://120.24.161.253:5617/index.php?title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-HER2%E5%9F%BA%E5%9B%A0%E6%89%A9%E5%A2%9E&diff=551136&oldid=prev 2021-11-22T13:12:30Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2021年11月22日 (一) 13:12的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-HER2%E5%9F%BA%E5%9B%A0%E6%89%A9%E5%A2%9E&diff=551131&oldid=prev 2021-10-19T13:56:59Z

<p>修改1</p> <p><b>新页面</b></p><div>主实体：[[乳腺癌]]，关系：[[临床表现]] ，尾实体：[[HER2基因扩增]]<br /> <br /> 实体ID:''661883''<br /> ==关系介绍==<br /> 待补充<br /> <br /> ==来源==<br /> ===FISH在乳腺癌组织HER2/neu原癌基因检测上的应用及其临床意义的研究（中华医学会文献）===<br /> 结果 42例[[乳腺癌]]中c-erbB2蛋白表达(+++)者22例(52.38%),表达(++)者20例(47.62%);42例[[乳腺癌]]中有20例(47.62%)出现[[HER2基因扩增]],22例(5238%)无扩增.<br /> <br /> ===FISH检测乳腺癌HER2基因扩增及临床病理关系的研究（中华医学会文献）===<br /> 结果:105例[[乳腺癌]]中共有39例[[HER2基因扩增]],阳性率为37.1% (39/105),其扩增与HER2蛋白过表达、组织学分级、雌激素和孕激素受体(均P&lt;0.05)状态有关;FISH与IHC两种方法检测HER2结果密切相关(rs=0.680,P&lt;0.05)</div>

Admin